About this trial
To achieve rapid, intelligent and accurate microbiological diagnosis and treatment for ICU pneumonia, an artificial neural network model for microbiological diagnosis is established, which depends on many clinical cases and machine deep learning from clinical experts' judgements according to species-specific rapid detection of pathogenic bacteria and other clinical parameter variables of patients.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
aged ≥18 years;
agreed to obtain lower respiratory specimens for rapid testing of pathogenic bacteria;
all were enrolled by an experienced physician who dynamically determined that the microorganisms were in a colonised or infected state;
signed an informed consent form.
Disqualifiers
pregnant women;
lactating women;
patients who could not obtain lower respiratory specimens;
Trial population
Pneumonia patients who admitted to Nanjing Drum Tower Hospital from Jan 1,2025 to Dec 31,2027 and meet the inclusion criteria.
Trial design
Other
Prospective
Treatments tested in this trial
establish an artificial neural network model
Other interventionto establish an artificial neural network model for pathogen diagnosis in ICU pneumonia
Treatment groups
Trial outcomes
Primary outcomes
clinical evaluation of each microbial detected whether in colonization or infection
Two experienced senior physicians are organized to determine whether the microbial are colonized or infected according to clinical values.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: